A lot of developments regarding the global governance of antimicrobial resistance took place in recent years. It is yet difficult to understand the ‘anatomy’ of the current regime complex addressing this issue. It was precisely this topic that framed Didier Wernli’s PhD thesis.

In 2016, the UN created the Interagency Cooperation Group on Antimicrobial Resistance (IACG-AMR). This group was composed of country officials as well as experts from several countries. It received the mandate to reflect on the future of the global governance of antimicrobial resistance. In December 2017, the Wellcome Trust, a big funder of health research, posted a tender on a project about the role and responsibilities of international organisations in addressing antimicrobial resistance. For the research team, this post was an opportunity to work at the science/policy interface.

Where do you see the major challenges in this project concerning processes and stakeholders? Write down your thoughts. Could you provide insightful arguments to an interviewer?

Educator: Dr. Didier Wernli

Downloads